Abstract Submission

Select SessionSession 1 (Ethics in Infectious Disease Research & Policy)Session 2 (Infection Prevention in Low-Resource Settings)Session 3 (Vector-Borne Diseases: Surveillance & Control)Session 4 (Sexually Transmitted Infections: Prevention & Treatment)Session 5 (Tuberculosis and Other Mycobacterial Infections)Session 6 (Respiratory Viruses & Pandemic Preparedness)Session 7 (Clinical Trials for Anti-infective Agents)Session 8 (Host Genetics and Susceptibility to Infection)Session 9 (Environmental Reservoirs and Pathogen Ecology)Session 10 (Transmission Dynamics and Contact Tracing)Session 11 (Public Health Policy and Infection Control Practices)Session 12 (Global Infectious Disease Modeling & Prediction)Session 13 (Innate Immunity and Interferon Responses)Session 14 (Bacteriophage Biology and Therapeutic Use)Session 15 (Viral Evolution, Mutation & Variant Tracking)Session 16 (Healthcare-Associated Infections (HAIs))Session 17 (Zoonotic Diseases: Surveillance and Control)Session 18 (Outbreak Investigation & Response Strategies)Session 19 (Immunology of Infection and Host Responses)Session 20 (Vaccines: Development, Efficacy & Uptake)Session 21 (Rapid Point-of-Care Diagnostic Technologies)Session 22 (Next-Generation Sequencing for Pathogen Surveillance)Session 23 (One Health Approaches to Infectious Disease Control)Session 24 (Viral Pathogenesis and Immune Evasion)Session 25 (Bacterial Pathogenesis and Host Interactions)Session 26 (Antimicrobial Resistance (AMR) Mechanisms & Solutions)Session 27 (Clinical Microbiology and Diagnostic Innovations)Session 28 (Bioinformatics & Computational Epidemiology)Session 29 (Antiviral and Antibiotic Therapeutics)Session 30 (Emerging and Re-emerging Infectious Diseases)